Little Green Pharma Ltd. (AU:LGP) has released an update.
Little Green Pharma Ltd. reported a record-breaking quarter with a 40% revenue increase to $10.2 million, driven by expanded market reach in Europe and a broad product portfolio. The company is capitalizing on new opportunities in Germany, the UK, Poland, and France, while also implementing cost-saving measures and strategic partnerships to fuel growth. This progress underscores LGP’s commitment to delivering innovative treatments and increasing shareholder value.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.